Search results
Results from the WOW.Com Content Network
The National Microbiology Laboratory was preceded by the Bureau of Microbiology which was originally part of the Laboratory Centre for Disease Control of Health Canada in Ottawa. In the 1980s, Health Canada identified both the need to replace existing laboratory space that was reaching the end of its lifespan and the need for Containment Level ...
This operations centre is the hub of the National Microbiology Laboratory when there is an outbreak or a deployment of personnel off-site. It is equipped with three separate phone systems, can videoconference with 38 participants at a time, and can connect via satellite to remote locations around the world.
The National Centre for Foreign Animal Disease (NCFAD), located in the Canadian Science Centre for Human and Animal Health in Winnipeg, Manitoba, is part of the Canadian Food Inspection Agency’s National Centres for Animal Disease. NCFAD is co-located with the Public Health Agency of Canada’s National Microbiology Laboratory.
The PHAC headquarters are located in two pillars—one is in Ottawa, and the other is the National Microbiology Laboratory in Winnipeg, Manitoba, the location of Canada's only Level 4 microbiology lab for human health. Both the President and the CPHO officiate from Ottawa.
Additionally, he was the chief of the Special Pathogens Unit at the National Microbiology Laboratory (NML) of the Public Health Agency of Canada (PHAC) in Winnipeg, Manitoba, for eight years. [1] Kobinger is known for his critical role in the development of both an effective Ebola vaccine and treatment.
On returning to Canada in 1999, he became senior scientific advisor to the Public Health Agency of Canada, director general of the Centre for Infectious Disease Prevention and Control, and scientific director general of the National Microbiology Laboratory, [2] [4] where he remained for 13 years, leading the Canadian laboratory response to SARS ...
Two of the drug's three components were originally developed at the Public Health Agency of Canada's National Microbiology Laboratory (NML), and a third at the U.S. Army Medical Research Institute of Infectious Diseases; [2] the cocktail was optimized by Gary Kobinger, then branch chief of the NML, and is undergoing further development by Leaf ...
[5] [13] [12] [14] It was created by scientists at the National Microbiology Laboratory in Winnipeg, Manitoba, Canada, which is part of the Public Health Agency of Canada (PHAC). [15] [16] PHAC licensed it to a small company, Newlink Genetics, which started developing the vaccine; Newlink in turn licensed it to Merck in 2014. [17]